CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Signifikans ApS

Signifikans ApS

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Mar 1, 2017

Timeline

2000s

Jan 1, 2002
Signifikans ApS— Founded

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

natalizumab

Other trials (1 own, 0 via acquisition)

bifidobacterium breve

Indications

Studied for

Recent trials (2)

NCT03027583CollaboratorN/AMar 1, 2017
NCT01077466CollaboratorPhase 2Mar 1, 2010

Details

Founded: Vedbaek, DK Jan 1, 2002
Last known activity: Mar 1, 2017